Marker Therapeutics, Inc. (MRKR): Net Income
-$12.16M
Year ended 2025-12-31
-$8.71M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$12.16M | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | -$10.73M | n/m | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | -$8.24M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$29.93M | n/m | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$41.88M | n/m | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$28.71M | n/m | 2022-03-17, From 2020-01-01 |
| 2019-12-31 | -$21.43M | n/m | 2021-03-09, From 2019-01-01 |
| 2018-12-31 | -$147.96M | n/m | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | -$10.98M | n/m | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | -$2.46M | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$34.07M | n/m | 2017-03-14, From 2015-01-01 |
| 2014-12-31 | -$30.88M | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$5.53M | n/m | 2015-04-15, From 2013-01-01 |
| 2012-12-31 | -$5.86M | n/m | 2013-05-15, From 2012-01-01 |
| 2011-12-31 | -$2.03M | n/m | 2013-05-15, From 2011-01-01 |
| 2010-12-31 | -$3.53M | n/m | 2012-04-16, From 2010-01-01 |
| 2009-12-31 | -$17.35M | n/m | 2012-04-16, From 2009-01-01 |
| 2008-12-31 | -$2.20M | n/m | 2012-04-16, From 2008-01-01 |
| 2007-12-31 | -$3.89M | n/m | 2012-04-16, From 2007-01-01 |
| 2006-12-31 | -$1.30M | n/m | 2012-04-16, From 2006-01-01 |
| 2005-12-31 | -$985.6K | n/m | 2012-04-16, From 2005-01-01 |
| 2004-12-31 | -$2.68M | n/m | 2012-04-16, From 2004-01-01 |
| 2003-12-31 | -$5.78M | n/m | 2012-04-16, From 2003-01-01 |
| 2002-12-31 | -$2.28M | n/m | 2012-04-16, From 2002-01-01 |
| 2001-12-31 | -$672.0K | n/m | 2012-04-16, From 2001-01-01 |
| 2000-12-31 | -$935.3K | n/a | 2012-04-16, From 2000-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$12.16M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$80.40M | n/m |
| CervoMed Inc. (CRVO) | 2025-12-31 | -$26.97M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$3.19M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$569.0K | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.68M | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$14.74M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$143.44M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$130.30M | n/m |
Compare MRKR, CAMP, CRVO, CPHI side by side · Screen every company in Pharmaceutical Preparations ↗